Skip to content

800.850.4306

  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Insights
    • News
    • Media
    • Events
  • About Us
    • Who We Are
    • Careers
  • Contact
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe
  • Patients
    • Rare and Orphan Care
  • Providers
    • Risk-Based Care
    • Financial Assistance
    • Rare and Orphan Care
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
  • Payers
  • How to Prescribe

Tag: TRUQAP

TRUQAP (capivasertib), FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson

Biologics has been selected as a specialty pharmacy provider for TRUQAP (capivasertib) for the treatment of breast cancer.

CARY, N.C., Dec.1, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by AstraZeneca […]

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2024 McKesson Corporation. All Rights Reserved.